Our findings demonstrated that HMGB1 overexpression led to increased PD-L1 expression and larger tumor size compared to controls, whereas HMGB1 knockdown resulted in decreased PD-L1 levels and smaller tumors. This evidence concerns the gene HMGB1 and neoplasm.